Cited by 1,513Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, Mike, Crawford, Fiona, Axelman, Karin, Houlden, Henry, Lilius, Lena, Winblad, Bengt, Lannfelt, Lars·1992·Nature Genetics

DOI 10.1038/ng0892-345

Open this paper in CoChat — free account

Abstract

Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.

Integrity signals

Registry

Crossref · 10.1038/ng0892-345

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Self-citation
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 2

Hardy, J. et al. Lancet 337, 1342–1343 (1991).
Weeks, D.E., Ott, J. & Lathrop, G M. Am. J. hum. Genet. 47(3), A204 (1990).

Sorted by citations

Items 301–400 of 1,002

Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques.
Fukumoto, H., Asami-Odaka, A., Suzuki, N., Shimada, H., Ihara, Y., & Iwatsubo, T. (1996) · Europe PMC (PubMed Central) · Cited by 108
Genes, models and Alzheimer's disease
Chapman, P. F., Falinska, A. M., Knevett, S. G., & Ramsay, M. F. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02285-5 · Cited by 108
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 115
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases
Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 108
Genetically modified pigs for biomedical research
Luo, Y., Lin, L., Bolund, L., Jensen, T. G., & Sørensen, C. B. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9475-0 · Cited by 107
Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice
Qosa, H., Mohamed, L. A., Batarseh, Y. S., Alqahtani, S., Ibrahim, B. A., LeVine, H., Keller, J. N., & Kaddoumi, A. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.022 · Cited by 113
Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity
Bao, F., Wicklund, L., Lacor, P. N., Klein, W. L., Nordberg, A. K., & Marutle, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.003 · Cited by 112
Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation
Kumar‐Singh, S., Dewachter, I., Moechars, D., Lübke, U., Jonghe, C. D., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P. P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 106
Intracellular Accumulation of β-Amyloid in Cells Expressing the Swedish Mutant Amyloid Precursor Protein
Martin, B. L., Schrader‐Fischer, G., Busciglio, J. A., Duke, M., Paganetti, P., & Yankner, B. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26727 · Cited by 104
Genetics, Transcriptomics, and Proteomics of Alzheimers Disease
Papassotiropoulos, A., Fountoulakis, M., Dunckley, T. L., Stephan, D. A., & Reiman, E. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0418 · Cited by 105
Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation
Yoshiike, Y., Chui, D., Akagi, T., Tanaka, N., & Takashima, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212785200 · Cited by 105
Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation
Shafaati, M., Marutle, A., Pettersson, H. I., Lövgren‐Sandblom, A., Olin, M., Pikuleva, I. A., Winblad, B. G., Nordberg, A. K., & Björkhem, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014548 · Cited by 102
Self-citation
β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptide
Paganetti, P., Calanca, V., Galli, C., Stefani, M., & Molinari, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410047 · Cited by 102
Amyloid β protein levels in cerebrospinal fluid are elevated in early‐onset Alzheimer's disease
Nakamura, T., Shoji, M., Harigaya, Y., 渡辺, 光., Hosoda, K., Cheung, T. T., Shaffer, L. M., Golde, T. E., Younkin, L. H., Younkin, S. G., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360616 · Cited by 103
Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH
Gorman, P. M., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01279-2 · Cited by 100
Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of β-Amyloid Peptides
Wang, S. S. ‐., Rymer, D. L., & Good, T. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102834200 · Cited by 101
Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives
Farrer, L. A., Cupples, L. A., van Duijn, C. M., Kurz, A., Zimmer, R., Müller, U., Green, R. C., Clarke, V., Shoffner, J. M., Wallace, D. C., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380515 · Cited by 100
Amyloid‐β oligomers are inefficiently measured by enzyme‐linked immunosorbent assay
Stenh, C., Englund, H., Lord, A., Johansson, A., Almeida, C. G., Gellerfors, P., Greengard, P., Gouras, G. K., Lannfelt, L., & Nilsson, L. N. G. (2005) · Annals of Neurology · doi:10.1002/ana.20524 · Cited by 99
Self-citation
Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice
Batarseh, Y. S., Bharate, S. S., Kumar, V., Kumar, A., Vishwakarma, R. A., Bharate, S. B., & Kaddoumi, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00101 · Cited by 100
Behavior of neural stem cells in the Alzheimer brain
Waldau, B., & Shetty, A. K. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8053-y · Cited by 101
Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P. W., Lannfelt, L., & Nilsson, L. N. G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 101
Self-citation
The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
Dislich, B., & Lichtenthaler, S. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00008 · Cited by 102
Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: Emphasis on Alzheimer's disease and Parkinson's disease
James, J. R., & Nordberg, A. K. (1995) · Behavior Genetics · doi:10.1007/bf02196924 · Cited by 100
Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description
Haltia, M., Viitanen, M. H., Sulkava, R. O., Ala‐Hurula, V., Pöyhönen, M., Goldfarb, L. G., Brown, P., Levy, E., Houlde, H., Crook, R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360307 · Cited by 98
Self-citation
Role of neurotransmission in the regulation of amyloid β-protein precursor processing
Nitsch, R. M., & Growdon, J. H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90325-5 · Cited by 99
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
Welzel, A. T., Maggio, J. E., Shankar, G. M., Walker, D., Ostaszewski, B. L., Li, S., Klyubin, I. V., Rowan, M. J., Seubert, P. A., Walsh, D. M., et al. (2014) · Biochemistry · doi:10.1021/bi5003053 · Cited by 102
Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies
Martinelli, A. H. S., Lopes, F. C., John, E. B. D. O., Carlini, C. R., & Ligabue‐Braun, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061322 · Cited by 99
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Salvadores, N., Gerónimo‐Olvera, C., & Court, F. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581767 · Cited by 101
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.043 · Cited by 97
Prevalence and incidence of major depression in Alzheimer's disease
Weiner, M., Edland, S. D., & Luszczynska, H. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1006 · Cited by 99
A Genome Survey for Novel Alzheimer Disease Risk Loci: Results at 10-cM Resolution
Zubenko, G. S., Hughes, H. B., Stiffler, J. S., Hurtt, M. R., & Kaplan, B. B. (1998) · Genomics · doi:10.1006/geno.1998.5306 · Cited by 97
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 102
Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease
Selkoe, D. J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90014-0 · Cited by 96
β-Amyloid Precursor Protein
Tischer, E., & Cordell, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21914 · Cited by 96
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders
Hook, G., Reinheckel, T., Ni, J., Wu, Z., Kindy, M. S., Peters, C., & HOOK, V. Y. H. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000527 · Cited by 98
Expression of APP in transgenic mice: a Comparison of neuron-specific promoters
Andrä, K., Abramowski, D., Duke, M., Probst, A., Wiederhold, K.-H., Bürki, K., Goedert, M., Sommer, B., & Staufenbiel, M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02066-7 · Cited by 95
Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D
Säftig, P., Peters, C., FIGURA, K. V., Craessaerts, K., LEUVEN, F. V., & Strooper, B. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27241 · Cited by 95
The Solved and Unsolved Mysteries of the Genetics of Early-Onset Alzheimer 's Disease
Rogaeva, E. A. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:1:01 · Cited by 96
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 93
Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence
Kimura, A., Hata, S., & Suzuki, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744722 · Cited by 95
The Vacuolar H+-ATPase Inhibitor Bafilomycin A1 Differentially Affects Proteolytic Processing of Mutant and Wild-type β-Amyloid Precursor Protein
Haass, C., Capell, A., Citron, M., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6186 · Cited by 98
Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo
Cao, L., Schrank, B. R., Rodriguez, S., Benz, E. G., Moulia, T. W., Rickenbacher, G. T., Gomez, A. C., Levites, Y., Edwards, S. R., Golde, T. E., et al. (2012) · Nature Communications · doi:10.1038/ncomms2013 · Cited by 93
Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers
Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13772 · Cited by 92
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
Cebers, G., Alexander, R., Haeberlein, S. B., Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L. B., Russell, M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160701 · Cited by 92
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 92
Altered cleavage and secretion of a recombinant β–APP bearing the Swedish familial Alzheimer's disease mutation
Felsenstein, K. M., Hunihan, L. W., & Roberts, S. B. (1994) · Nature Genetics · doi:10.1038/ng0394-251 · Cited by 90
Sex‐biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi‐omic analysis
Bundy, J. L., Vied, C., Badger, C., & Nowakowski, R. S. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24551 · Cited by 90
Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
Takahashi, M., Miyata, H., Kametani, F., Nonaka, T., Akiyama, H., Hisanaga, S., & Hasegawa, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1415-2 · Cited by 101
Alzheimer’s disease – the journey of a healthy brain into organ failure
Golde, T. E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00523-1 · Cited by 98
Repositioning Microtubule Stabilizing Drugs for Brain Disorders
Varidaki, A., Hong, Y., & Coffey, E. T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00226 · Cited by 93
Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family
Lannfelt, L., Bogdanović, N., Appelgren, H., Axelman, K., Lilius, L., Hansson, G. K., Schenk, D., Hardy, J., & Winblad, B. G. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90463-4 · Cited by 89
Self-citation
Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene
MULLAN, M. J., Tsuji, S., Miki, T., Katsuya, T., Naruse, S., Kaneko, K., Shimizu, T., Kojima, T., Nakano, I., Ogihara, T., et al. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90099-w · Cited by 89
Self-citation
Inhibition of Amyloid β-Protein Production in Neural Cells by the Serine Protease Inhibitor AEBSF
Citron, M., Diehl, T. S., Capell, A., Haass, C., Teplow, D. B., & Selkoe, D. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80290-1 · Cited by 89
Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome
Zis, P., & Strydom, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.024 · Cited by 90
Aβ-induced vulnerability propagates via the brain’s default mode network
Pascoal, T. A., Mathotaarachchi, S. S., Kang, M. S., Mohaddes, S., Shin, M., Park, A. Y., Parent, M. J., Benedet, A. L., Chamoun, M., Therriault, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10217-w · Cited by 90
Transgenic Mouse Models of Alzheimer's Disease
Bornemann, K. D., & Staufenbiel, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06653.x · Cited by 89
Traffic-related air pollutants (TRAP-PM) promote neuronal amyloidogenesis through oxidative damage to lipid rafts
Cacciottolo, M., Morgan, T. E., Saffari, A. A., Shirmohammadi, F., Forman, H. J., Sioutas, C., & Finch, C. E. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.023 · Cited by 88
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism
Vingtdeux, V., Hamdane, M., Gompel, M., Bégard, S., Drobecq, H., Ghestem, A., Grosjean, M., Kostanjevečki, V., Grognet, P., Vanmechelen, E., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.004 · Cited by 86
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
Ordóñez‐Gutiérrez, L., Re, F., Bereczki, E., Ioja, E., Gregori, M., Andersen, A. J., Antón, M., Moghimi, S. M., Pei, J.-J., Masserini, M., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.015 · Cited by 86
Decreased Plasma Insulin-Like Growth Factor-I Level in Familial Alzheimer’s Disease Patients Carrying the Swedish APP 670/671 Mutation
Mustafa, A., Lannfelt, L., Lilius, L., Islam, A., Winblad, B. G., & Adem, A. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017188 · Cited by 86
Self-citation
Genetic factors in Alzheimer's disease: A review of recent advances
Levy‐Lahad, E., & Bird, T. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400604 · Cited by 86
Lysosomal processing of amyloid precursor protein to Aβ peptides: a distinct role for cathepsin S
Munger, J. S., Haass, C., Lemere, C. A., Shi, G., Wong, W., Teplow, D. B., Selkoe, D. J., & Chapman, H. A. (1995) · Biochemical Journal · doi:10.1042/bj3110299 · Cited by 85
Skin and brain age together: The role of hormones in the ageing process
Makrantonaki, E., Schönknecht, P., Hossini, A. M., Kaiser, E., Katsouli, M.-M., Adjaye, J., Schröder, J., & Zouboulis, C. C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.005 · Cited by 88
Genetic background regulates -amyloid precursor protein processing and -amyloid deposition in the mouse
Lehman, E. J. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg322 · Cited by 85
Cerebral Amyloid Angiopathy
(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00006-0 · Cited by 84
Shifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions
Chen, J., Wang, J., Yin, B., Pang, L., Wang, W., & Zhu, W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00348 · Cited by 84
The Links between Cardiovascular Diseases and Alzheimer's Disease
Leszek, J., Вячеславовна, М. Е., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak−Prokopowicz, M., Mysiak, A., Diniz, B. S., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729093724 · Cited by 93
Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein
Sopher, B. L., Fukuchi, K.-I., Smith, A. C., Leppig, K. A., Furlong, C. E., & Martin, G. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90092-2 · Cited by 84
Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation
Pérez, M., Ribé, E. M., Rubio, A., Lim, F., Morán, M. A., Gómez‐Ramos, P., Ferrer, I., Isla, M. T. G., & Ávila, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.029 · Cited by 85
Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide
Clements, A., Walsh, D. M., Williams, C. H., & Allsop, D. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90129-9 · Cited by 83
β-Amyloid Prions and the Pathobiology of Alzheimer’s DiseasePreprint
Watts, J. C., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023507 · Cited by 90
SUMO and Its Role in Human Diseases
Sarge, K. D., & Park-Sarge, O.-K. (2011) · International review of cytology · doi:10.1016/b978-0-12-386041-5.00004-2 · Cited by 82
Protein Kinase C ϵ Suppresses Aβ Production and Promotes Activation of α-Secretase
Zhu, G., Wang, D., Lin, Y., McMahon, T., Koo, E. H., & Messing, R. O. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5273 · Cited by 82
Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5599-9 · Cited by 83
Ectodomain Phosphorylation of β-Amyloid Precursor Protein at Two Distinct Cellular Locations
Walter, J., Capell, A., Hung, A. Y., Langen, H., Schnölzer, M., Thinakaran, G., Sisodia, S. S., Selkoe, D. J., & Haass, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1896 · Cited by 84
The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update
Mahoney‐Sanchez, L., Belaidi, A. A., Bush, A. I., & Ayton, S. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0839-z · Cited by 84
Heparan Sulfate Accumulation with Aβ Deposits in Alzheimer's Disease and Tg2576 Mice is Contributed by Glial Cells
O'Callaghan, P. W., Sandwall, E., Li, J.-P., Yu, H., Ravid, R., Guan, Z., Kuppevelt, T. H. V., Nilsson, L. N. G., Ingelsson, M., Hyman, B. T., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00152.x · Cited by 81
Self-citation
Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein — initial observations
Diez, M., Koıstınaho, J., Kahn, K., Games, D., & Hökfelt, T. G. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00261-x · Cited by 81
Impairment of hippocampal gamma (γ)‐frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP)
Driver, J. E., Racca, C., Cunningham, M. O., Towers, S. K., Davies, C. H., Whittington, M. A., & LeBeau, F. E. N. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05705.x · Cited by 83
Intracellular Production of .beta.A4 Amyloid of Alzheimer's Disease: Modulation by Phosphoramidon and Lack of Coupling to the Secretion of the Amyloid Precursor Protein
Fuller, S. J., Storey, E., Li, Q.-X., Smith, A. I., Beyreuther, K., & Masters, C. L. (1995) · Biochemistry · doi:10.1021/bi00025a015 · Cited by 80
Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models
Naia, L., Shimozawa, M., Bereczki, E., Li, X., Liu, J., Jiang, R., Giraud, R., Leal, N. S., Pinho, C. M., Berger, E., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02289-4 · Cited by 79
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
Cerebrospinal Fluid Levels of -Secretase--Cleaved Soluble Amyloid Precursor Protein Mirror Cognition in a Swedish Family With Alzheimer Disease and a Gene Mutation
Almkvist, O., Basun, H., Wagner, S. L., Rowe, B. A., Wahlund, L., & Lannfelt, L. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170111022 · Cited by 83
Self-citation
Bilateral Injections of Amyloid-β 25-35 into the Amygdala of Young Fischer Rats: Behavioral, Neurochemical, and Time Dependent Histopathological Effects
Sigurdsson, E. M., Lee, J. M., Dong, X.-W., Hejna, M. J., & Lorens, S. A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00154-1 · Cited by 81
Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components
Storey, E., Beyreuther, K. T., & Masters, C. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00608-7 · Cited by 79
Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment
Theuns, J., Marjaux, E., Vandenbulcke, M., Laere, K. V., Kumar‐Singh, S., Bormans, G. M., Brouwers, N., den Broeck, M. V., Vennekens, K. M., Corsmit, E., et al. (2006) · Human Mutation · doi:10.1002/humu.20402 · Cited by 82
Secretion and Intracellular Generation of Truncated Aβ in β-Site Amyloid-β Precursor Protein-cleaving Enzyme Expressing Human Neurons
Lee, E. B., Skovronsky, D., Abtahian, F., Doms, R. W., & Lee, V. M. ‐. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210105200 · Cited by 78
Cathepsin D displays in vitro β-secretase-like specificity
Chevallier, N., Vizzavona, J., Marambaud, P., Baur, C.-P., Spillantini, M. G., Fulcrand, P., Martínez, J., Goedert, M., Vincent, J., & Checler, F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01330-3 · Cited by 78
Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
Soto, C. A. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050371 · Cited by 78
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
Castello, M. A., Jeppson, J. D., & Soriano, S. (2014) · BMC Neurology · doi:10.1186/s12883-014-0169-0 · Cited by 80
The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid
Tam, J. H. K., Seah, C., & Pasternak, S. (2014) · Molecular Brain · doi:10.1186/s13041-014-0054-1 · Cited by 83
Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex
Echeverrı́a, V., Ducatenzeiler, A., Alhonen, L. I., Jänne, J., Grant, S. M., Wandosell, F. G., Muro, A. F., Baralle, F. E., Li, H., Duff, K., et al. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6301 · Cited by 82
Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice.
Pearson, B. E., & Choi, T. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10578 · Cited by 77
Complement System in Alzheimer’s Disease
Shah, A., Kishore, U., & Shastri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413647 · Cited by 76
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
Rostagno, A. A., Holton, J. L., Lashley, T., Révész, T., & Ghiso, J. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0182-4 · Cited by 80
Apolipoprotein E4 allele and Alzheimer disease: Examination of Allelic association and effect on age at onset in both early‐and late‐onset cases
Locke, P. A., Conneally, P. M., Tanzi, R. E., Gusella, J. F., & Haines, J. L. (1995) · Genetic Epidemiology · doi:10.1002/gepi.1370120108 · Cited by 75
Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
Kulshreshtha, A., & Piplani, P. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2625-7 · Cited by 76
Genetic Markers of Alzheimer’s Disease
Perković, M. N., & Pivac, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_3 · Cited by 82

Authors: Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L.
Affiliations: University of South Florida (US)
Karolinska Institutet (SE)
St Mary's Hospital (GB)
ORCID: Crawford, Fiona
Houlden, Henry
Winblad, Bengt
Lannfelt, Lars
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1992-08
Volume: 1
Issue: 5
Pages: 345-347
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0892-345
OpenAlex: W2030641075
Cited by: 1,513
References: 22
Citations by year: 2026: 24 · 2025: 30 · 2024: 50 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 52 · 2019: 56 · 2018: 48 · 2017: 48 · 2016: 47 · 2015: 31 · 2014: 62 · 2013: 31 · 2012: 32
FWCI: 49.77
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, APP gene, amyloid-beta, early-onset familial Alzheimer's disease, Swedish families
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Base Sequence, Brain, Codon, Exons, Female, Humans, Genetic Linkage, Male, Middle Aged, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Transcription, Genetic, Genetic Variation, Amyloid beta-Protein Precursor, Point Mutation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks